Anavex Life Sciences Corp (AVXL)

[georgejjl]

NO BLINDING OF THE Open Label Extension Study for Patients With Early Alzheimer's Disease (AD) Enrolled in Study ANAVEX2-73-AD-004

https://clinicaltrials.gov/ct2/show/NCT04314934

Dr. Missling and Anavex have confidence in the success of the Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled 48-week Safety and Efficacy Trial of ANAVEX2-73 for the Treatment of Early Alzheimer's Disease (AD) and the follow on Open Label Extension Study for Patients With Early Alzheimer's Disease (AD) Enrolled in Study ANAVEX2-73-AD-004.

What is next???

Anavex planning a Phase 3 prevention trial of ANAVEX®2-73 including participants at risk for cognitive and functional decline related to Alzheimer’s disease

https://www.anavex.com/anavex-life-sciences-announces-anavex2-73-blarcamesine-significantly-prevented-a%ce%b2-abeta-induced-cognitive-deficits-with-confirmed-significant-biomarker-response-in-animal-model-of-alzhe/


Good luck and GOD bless,